Animal models of gastroduodenal ulcer disease

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 1, 2000, Pages 75-96

  Lee, Adrian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Animal models; Duodenal ulcer; Gastric ulcer; Gastritis; H. pylori; NSAID; Peptic ulcer; Stress ulcer

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLSALICYLIC ACID; ANTIULCER AGENT; CARBACHOL; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIN; ENZYME INHIBITOR; EPIRIZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; MELOXICAM; MERCAPTAMINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PENTAGASTRIN; PROSTAGLANDIN; PROTON PUMP INHIBITOR; RANITIDINE; SODIUM HYDROXIDE; TETRAGASTRIN;

BACTERIAL VIRULENCE; CAT; CELL PROTECTION; CLINICAL TRIAL; EXPERIMENTAL INFECTION; EXPERIMENTAL MODEL; FERRET; GASTRITIS; GASTRODUODENAL ULCER; GERBIL; GUINEA PIG; HELICOBACTER PYLORI; IMMUNE RESPONSE; KNOCKOUT MOUSE; NONHUMAN; PRIMATE; PROSTAGLANDIN RELEASE; REVIEW; RODENT; STOMACH BLOOD FLOW; STOMACH EPITHELIUM; STOMACH MUCOSA LESION; STRESS ULCER; SWINE; TISSUE REGENERATION; TRANSGENIC MOUSE;

EID: 0034104759     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2000.0060     Document Type: Article

References (118)

1. Silen W. Experimental models of gastric ulceration and injury. Gastrointestinal and Liver Physiology. 18:1988;G395-G402.
2. Chaudhury T K, Jacobsen E D. Prostaglandin cytoprotection of gastric mucosa. Gastroenterology. 74:1978;59-63.
3. Robert A, Nezamis J E, Lancaster C. Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by Alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 77:1979;433-443.
4. McQueen S, Hutton D, Allen A. Gastric and duodenal surface mucus gel thickness in rat: effects of prostaglandins and damaging agents. American Journal of Physiology. 245:1983;388.
5. Gerber J G, Nies A S. Canine gastric mucosal vasodilation with prostaglandins and histamine analogs. Digestive Diseases Science. 27:1982;870.
6. Kauffman G L, Reeve J J, Grossman M I. Gastric bicarbonate secretion: effect of topical and intravenous 16, 16-dimethyl prostaglandin E2. American Journal of Physiology. 239:1980;44.
7. Lacy E R, Ito S. Rapid epithelial restitution of the rat gastric mucosa after ethanol injury. Laboratory Investigation. 51:1984;573-583.
8. Playford R J. Trefoil peptides - what they are and what they can do. Journal of the Royal College of Physicians of London. 31:1997;37-41.
9. Perry M, Wadhwa S, Parks D. Role of oxygen radicals in ischemia-induced lesions in the cat stomach. American Gastroenterological Association. 90:1986;362-367.
10. Wadhwa S, Perry M. Gastric Injury induced by hemorrhage, local ischemia, and oxygen radical generation. American Journal of Physiology. 253:1987;G129-G133.
11. Gronbech J E, Lacy E R. Role of gastric blood flow in impaired defense and repair of aged rat stomachs. American Journal of Physiology-Gastrointestinal and Liver Physiology. 32:1995;737-744.
12. Morris G P, Fallone C A, Pringle G C, MacNaughton W K. Gastric cytoprotection is secondary to increased mucosal fluid secretion: a study of six cytoprotective agents in the rat. Journal of Clinical Gastroenterology. 27:1998;S53-S63.
13. Carrick J, Lee A, Hazell S. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut. 30:1989;709-797.
14. Rhodes J. Experimental production of gastric epithelium in the duodenum. Gut. 5:1964;454-458.
15. Tatsuta M, Iishi H, Yamamura H. Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. Gut. 30:1989;311-315.
16. Raufman J P. Peptic activity and gastroduodenal mucosal damage. Yale Journal of Biology and Medicine. 69:1996;85-90.
17. Schiffrin M J, Warren A A. Some factors concerned in the production of experimental ulceration of the GI tract in cats. American Journal of Digestive Diseases. 9:1942;205-209.
18. Alphin R S, Vokac V A, Gregory R L. Role of intragastic pressure, pH, and pepsin in gastric ulceration in the rat. Gastroenterology. 73:1977;495-500.
19. Joffe S N, Roberts N B, Taylor W H, Baron J H. Exogenous and endogenous acid and pepsins in the pathogenesis of duodenal ulcers in the rat. Digestive Diseases Science. 25:1980;837-841.
20. Kinoshita M, Endo M, Yasoshima A. Ecabet sodium, a novel locally acting ulcer agent protects the integrity of the gastric mucosal gel layer from pepsin induced disruption in the rat. Alimentary Pharmacology and Therapeutics. 13:1999;687-694.
21. Szabo S, Vattay P. Experimental gastric and duodenal ulcers - advances in pathogenesis. Gastroenterology Clinics of North America. 19:1990;67-85.
22. Gaskin R J. Natural history and morphology of secretagogue-induced duodenal ulcers in rats. Gastroenterology. 69:1975;903-910.
23. Mangla J C, Pihan G, Brown H A. Effect of duodenal ulcerogens cysteamine, mepirizole, amd MPTP on duodenal myoelectric activity in rats. Digestive Diseases Science. 34:1989;537-542.
24. Briden S, Flemstrom G, Kivilaakso O. Cysteamine and proprionitrile inhibit the rise of duodenal mucosal alkaline secretion in response to luminal acid in rats. Gastroenterology. 88:1985;295-302.
25. Kusstatscher S, Sandor Z, Szabo S, Bohlen P. Different molecular forms of basic fibroblast growth factor (BFGF) accelerate duodenal ulcer healing in rats. Journal of Pharmacology and Experimental Therapeutics. 275:1995;456-461.
26. Szabo S, Kusstatscher S, Sandor Z, Sakoulas G. Molecular and cellular basis of ulcer healing. Scandinavian Journal of Gastroenterology. 30:1995;3-8.
27. Trevithick M A, Oakley I, Clayton N M, Strong P. Non-steroidal anti-inflammatory drug-induced gastric damage in experimental animals - underlying pathological mechanisms. General Pharmacology. 26:1995;1455-1459.
28. Bugat R, Thompson M R, Aures D, Grossman M I. Gastric mucosal lesions produced by intravenous infusion of aspirin in rats. Gastroenterology. 71:1976;754.
29. Kauffman G. Aspirin-induced gastric mucosal injury: lessons learned from animal models. Gastroenterology. 96:1989;606-614.
30. Redfern J S, Feldman M. Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins. Gastroenterology. 96:1989;596-605.
31. Konturek S J, Piastucki I, Brozozowski T. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology. 80:1981;4-9.
32. Kauffman G L, Aures D, Grossman M I. Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow in dogs. American Journal of Physiology. 238:1980;G131.
33. Wallace J L, Keenan C M, Granger D N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. American Journal of Physiology. 259:1990;G462-G467.
34. Trevithick M A, Bahl A K, Claytron N M. Neutrophil infiltration does not contribute to the ulcerogenic effects of indomethacin in the rat gastric antrum. Agents and Actions. 43:1995;39-43.
35. Wallace J L, Granger D N. The cellular and molecular basis of gastric mucosal defense. FASEB Journal. 10:1996;731-740.
36. Morise Z, Komatsu S, Fuseler J W. ICAM-1 and P-selectin expression in a model of NSAID-induced gastropathy. American Journal of Physiology - Gastrointestinal and Liver Physiology. 37:1998;G246-G252.
37. Lipsky P E. Specific COX-2 inhibitors in arthritis, oncology and beyond: where is the Science headed. Journal of Rheumatology. 26:1999;25-30.
38. Takeuchi K, Suzuki K, Yamamoto H. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses. Journal of Physiology and Pharmacology. 49:1998;501-513.
39. Wallace J L, Reuter B K, McKnight W, Bak A. Selective inhibitors of cyclooxygenase-2: Are they really effective and GI safe. Journal of Clinical Gastroenterology. 27:1998;528-534.
40. Mahler J F, Davis B J, Markaham S G, Lanenbach R. Disruption of cyclooxygenase genes in mice. Toxicology and Pathology. 24:1997;717-719.
41. Weiner H. Use of animal models in peptic ulcer disease. Psychosomatic Medicine. 58:1996;524-545.
42. Schiessel R, Feil W, Wenzel E. Mechanisms of stress ulceration and implications for treatment. Gastroenterology Clinics of North America. 19:1990;101-120.
43. Brodie D A. Experimental peptic ulcer. Gastroenterology. 55:1968;125-134.
44. Pare W, Burken M, Douglas Allen E, Kluczynski M. Reduced incidence of stress ulcer in germ-free Sprague Dawley rats. Life Science. 53:1993;1099-1104.
45. Schaedler R W, Dubos R, Costello R. The development of the bacterial flora in the gastrointestinal tract of mice. Journal of Experimental Medicine. 122:1965;59-66.
46. Said S, El-Mowafy A. Role of endogenous endothelin-1 in stress induced gastric mucosal damage and acid secretion in rats. Regulated Peptides. 73:1998;43-50.
47. Watanabe Y, Okumura T, Harada K, Kohgo Y. Effects of submucosal administration of endothelin-3 on rat gastric mucosa. Journal of Gastroenterology. 32:1997;148-156.
48. Kitajima T, Tani K, Yamaguchi T. Role of endogenous endothelin in gastric mucosal injury induced by hemorrhagic shock in rats. Digestion. 56:1995;111-116.
49. Cho C H. The role of endogenous ulcerogenic mediators in the pathogenesis of peptic ulcer. Life Sciences. 55:1994;1521-1535.
50. Graham J R. Helicobacter pylori: Human pathogen or simply an opportunist? Lancet. 345:1995;1095-1097.
51. Weiner H, Shapiro A P. Is Helicobacter pylori really the cause of gastroduodenal disease. QJM-Monthly Journal of The Association of Physicians. 91:1998;707-711.
52. Lee A, Robertson B. New Helicobacter species. Hunt R H, Tytgat G NJ. Helicobacter pylori: Basic Mechanisms to Clinical Cure 1998. 1998;3-12 Kluwer, Dordrecht.
53. Lee A, Hazell S L, O'Rourke J, Kouprach S. Isolation of a spiral-shaped bacterium from the cat stomach. Infection and Immunity. 56:1988;2843-2850.
54. Wegmann W, Aschwanden M, Schaub N. Gastritis associated with Gastrospirillum hominis - a zoonosis? Schweiz Med Wochenschr. 121:1991;245-254.
55. Lee A, Fox J G, Otto G, Murphy J. A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology. 99:1990;1315-1323.
56. Dick-Hegedus E, Lee A. Use of a mouse model to examine anti- Helicobacter pylori agents. Scandinavian Journal of Gastroenterology. 26:1991;909-915.
57. Chen M, Lee A, Hazell S L. Immunisation against Helicobacter infection in a mouse/ Helicobacter felis model. Lancet. 339:1992;1120-1121.
58. Enno A, O'Rourke J L, Howlett C R. MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis - a mouse model of Helicobacter pylori -induced gastric lymphoma. American Journal of Pathology. 147:1995;217-222.
59. Enno A, O'Rourke J, Braye S. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach - effects of antimicrobial therapy on gastric MALT lymphoma in mice. American Journal of Pathology. 152:1998;1625-1632.
60. McNulty C AM, Dent J C, Curry A. New spiral bacterium in gastric mucosa. Journal of Clinical Pathology. 42:1989;585-591.
61. Dick E, Lee A, Watson G, O'Rourke J. Use of the mouse for the isolation and investigation of stomach-associated, spiral-helical shaped bacteria from man and other animals. Journal of Medical Microbiology. 29:1989;55-62.
62. Solnick J V, O'Rourke J, Lee A, Tompkins L S. Gastrospirillum is a new species of Helicobacter in humans. Gastroenterology. 102:1992;A699.
63. Mendes E N, Queiroz D M, Rocha G A. Ultrastructure of a spiral micro-organism from pig gastric mucosa ("Gastrospirillum suis"). Journal of Medical Microbiology. 33:1990;61-66.
64. Fox J G, Correa P, Taylor N S. Helicobacter mustelae -associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology. 99:1990;352-361.
65. Otto G, Fox J G, Wu P Y, Taylor N S. Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapy. Antimicrobial Agents and Chemotherapy. 34:1990;1232-1236.
66. Cuenca R, Blanchard T G, Czinn S J. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 110:1996;1770-1775.
67. Krakowka S, Morgan D R, Kraft W G, Leunk R D. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infection and Immunity. 55:1987;2789-2796.
68. Lambert J R, Borromeo M, Pinkard K J. Colonization of gnotobiotic piglets with Campylobacter pyloridis - an animal model? Journal of Infectious Diseases. 155:1987;1344.
69. Radin M J, Eaton K A, Krakowka S. Helicobacter pylori gastric infection in gnotobiotic beagle dogs. Infection and Immunity. 58:1990;2606-2612.
70. Dubois A, Fiala N, Hemanackah L M. Natural gastric infection with Helicobacter pylori in monkeys: a model for spiral bacteria infection in humans. Gastroenterology. 106:1994;1405-1417.
71. Fox J G, Batchelder M, Marini R. Helicobacter pylori -induced gastritis in the domestic cat. Infection and Immunity. 63:1995;2674-2681.
72. McColm A A, Bagshaw J, O'Malley C, McLaren A. Development of a mouse model of gastric colonisation with Helicobacter pylori. Gut. 37:1995;A50.
73. Li H, Kalies I, Mellgard B, Helander H F. A rat model of chronic Helicobacter pylori infection - studies of epithelial cell turnover and gastric ulcer healing. Scandinavian Journal of Gastroenterology. 33:1998;370-378.
74. Lee A, O'Rourke J, De Ungria M C. A standardized mouse model of Helicobacter pylori infection - introducing the Sydney strain. Gastroenterology. 112:1997;1386-1397.
75. Covacci A, Telford J L, Del Giudice G. Helicobacter pylori virulence and genetic geography. Science. 284:1999;1328-1333.
76. Sakagami T, Dixon M, O'Rourke J. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut. 39:1996;639-648.
77. Wang T C, Goldenring J R, Dangler C. Mice lacking secretory phospholipase A(2) show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 114:1998;675-689.
78. Marchetti M, Arico B, Burroni D. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 267:1995;1655-1658.
79. Shomer N H, Dangler C A, Whary M T, Fox J G. Experimental Helicobacter pylori infection induces antral gastritis and gastric mucosa-associated lymphoid tissue in guinea pigs. Infection and Immunity. 66:1998;2614-2618.
80. Lee A, Dixon M F, Danon S J. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. European Journal of Gastroenterology and Hepatology. 7:1995;461-465.
81. Lee A, Mellgard B, Larsson H. Effect of gastric acid on Helicobacter pylori ecology. Hunt R H, Tytgat G NJ. Helicobacter pylori: Basic Mechanisms to Clinical Cure 1996. 1996;50-63 Kluwer, Dordrecht.
82. Danon S J, O'Rourke J L, Moss N D, Lee A. The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach. Gastroenterology. 108:1995;1386-1395.
83. Van Zanten S JOV, Dixon M F, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology. 116:1999;1217-1229.
84. Ermak T H, Giannasca P J, Nichols R. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. Journal of Experimental Medicine. 188:1998;2277-2288.
85. van Zanten S V, Leung V, O'Rourke J L, Lee A. The gastric transitional zones (TZ) are the areas where Helicobacter treatment fails. Results of a treatment trial using the Sydney strain. Gut. 43:1998;A80.
86. Eaton K A, Radin M J, Kramer L. Epizootic gastritis associated with gastric spiral bacilli in cheetahs (Acinonyx jubatus). Veterinary Pathology. 30:1993;55-63.
87. Eaton K A, Radin M J, Krakowka S. An animal model of gastric ulcer due to bacterial gastritis in mice. Veterinary Pathology. 32:1995;489-497.
88. Barbosa A JA, Silva J CP, Nogueira A MMF. Higher incidence of Gastrospirillum sp in swine with gastric ulcer of the pars oesophagea. Veterinary Pathology. 32:1995;134-139.
89. Queiroz D MD, Rocha G A, Mendes E N. Association between Helicobacter and gastric ulcer disease of the pars esophagea in swine. Gastroenterology. 111:1996;19-27.
90. Yokota K, Kurebayashi Y, Takayama Y. Colonization of Helicobacter pylori in the gastric mucosa of Mongolian gerbils. Microbiology and Immunology. 35:1991;475-480.
91. Hirayama F, Takagi S, Kusuhara H. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. Journal of Gastroenterology. 31:1996;755-757.
92. Hirayama F, Takagi S, Yokoyama Y. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. Journal of Gastroenterology. 31:1996;24-28.
93. Matsumoto S, Washizuka Y, Matsumoto Y. Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. Journal of Medical Microbiology. 46:1997;391-397.
94. Honda S, Fujioka T, Tokieda M. Gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylori infection in Mongolian gerbils. Scandinavian Journal of Gastroenterology. 33:1998;454-460.
95. Sawada Y, Kuroda Y, Sashio H. Pathological changes in glandular stomach of Helicobacter pylori -infected Mongolian gerbil model. Journal of Gastroenterology. 33:1998;22-25.
96. Takahashi S, Keto Y, Fujita H. Pathological changes in the formation of Helicobacter pylori -induced gastric lesions in Mongolian gerbils. Digestive Diseases Science. 43:1998;754-765.
97. Ikeno T, Ota H, Sugiyama A. Helicobacter pylori -induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. American Journal of Pathology. 154:1999;951-960.
98. Dixon M F, Genta R M, Yardley J H. Classification and grading of gastritis - the updated Sydney System. American Journal of Surgical Pathology. 20:1996;1161-1181.
99. Wirth H P, Beins M H, Yang M Q. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infection and Immunity. 66:1998;4856-4866.
100. Keto Y, Takahashi S, Okabe S. Healing of Helicobacter pylori -induced gastric ulcers in Mongolian gerbils combined treatment with omeprazole and clarithromycin. Digestive Diseases Science. 44:1999;257-265.
101. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 3:1969;87-97.
102. Kusuhara H, Hirayama F, Matsuyuki H. Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori -infected Mongolian gerbils. Journal of Gastroenterology. 33:1998;14-17.
103. Suzuki H, Mori M, Kai A. Effect of rebamipide on H. pylori -associated gastric mucosal injury in Mongolian gerbils. Digestive Diseases Science. 43:1998;S181-S187.
104. Sugiyama A, Maruta F, Ikeno T. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Research. 58:1998;2067-2069.
105. Shimizu N, Inada K, Nakanishi H. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis. 20:1999;669-676.
106. Honda S, Fujioka T, Tokieda M. Development of Helicobacter pylori -induced gastric carcinoma in Mongolian gerbils. Cancer Research. 58:1998;4255-4259.
107. Watanabe T, Tada M, Nagai H. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 115:1998;642-648.
108. IARC Monographs on the evaluation of carcinogenic risks to humans. 1994;World Health Organisation, Lyon. p. 177-240.
109. Brzozowski T, Konturek P C, Konturek S J. Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori. Journal of Physiology and Pharmacology. 49:1998;387-403.
110. Kodama R, Fujioka T, Shuto R. Helicobacter pylori infection delays the healing of acetic acid-induced gastric ulcer in Japanese monkeys. Journal of Gastroenterology and Hepatology. 11:1996;1097-1102.
111. Calam J. Clinical science of Helicobacter pylori infection - ulcers and NSAIDs. British Medical Bulletin. 54:1998;55-62.
112. Haas R, Odenbreit S, Heuermann D, Schmitt W. Transposon shuttle mutagenesis as a general tool to identify and genetically define virulence determinants ofHelicobacter pylori. Acta Gastro-Enterologica Belgica. 4087:1993.
113. Tomb J F, White O, Kerlavage A R. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 388:1997;539-547.
114. Alm R A, Ling L SL, Moir D T. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 397:1999;719.
115. Eaton K A, Cover T L, Tummuru M KR. Role of vacuolating cytotoxin in gastritis due to Helicobacter pylori in gnotobiotic piglets. Infection and Immunity. 65:1997;3462-3464.
116. Berg D J, Lynch N A, Lynch R G, Lauricella D M. Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis -infected IL-10(-/-) mice. American Journal of Pathology. 152:1998;1377-1386.
117. Guruge J L, Falk P G, Lorenz R G. Epithelial attachment alters the outcome of Helicobacter pylori infection. PNAS USA. 95:1998;3925-3930.
118. Syder A J, Guruge J L, Li Q T. Helicobacter pylori attaches to NeuAc alpha 2,3Gal beta 1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells. Molecular Cell. 3:1999;263-274.